Recent advances and challenges in antibacterial drug development
Cited by 41
Related Papers
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
|Bulletin of the World Health Organization|2023|276
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
|International Journal of Infectious Diseases|2021|256
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed
|Archive ouverte UNIGE (University of Geneva)|2022|221
Impact of climate change and natural disasters on fungal infections
|The Lancet Microbe|2024|204